People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AOA DX Inc. | — | Biotechnology | Series B | $38.7M | $33.7M | 2021 |
| NVISION MEDICAL Corp | — | Biotechnology | Series A | $10.8M | $236.0M | 2011 |
Surbhi Sarna at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Surbhi Sarna on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Friedman | 1 | 9 |
| Anula Jayasuriya | 1 | 5 |
| Darshana Zaveri | 1 | 5 |
| Thomas Shehab | 1 | 4 |
| Alexander James Fisher | 1 | 1 |
| Alexander Fisher | 1 | 1 |
| Oriana Zoghbi-Harb | 1 | 1 |
| Corinne Nevinny | 1 | 1 |
| Dashana Zaveri | 1 | 1 |
| Anna Milik Jeter | 1 | 1 |
| Abigail James Mcelhinny | 1 | 1 |
| Oriana Papin-Zoghbi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.